Thetford Mines, Quebec – TheNewswire - December 3, 2024 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative technological solutions for healthcare professionals, is pleased to announce an important update regarding our progress towards certification with the Québec Health Record / Dossier Santé Québec (“DSQ”), the province-wide platform enabling the secure exchange of prescriptions, laboratory results, and imaging between healthcare professionals and patients for our project Medherize.

As part of our commitment to integrating with the DSQ, we have successfully completed the development of all required functionalities for the first phase of the certification process. This represents a significant technical milestone, as the first phase is a critical component in ensuring that our application meets the stringent requirements for accessing the DSQ. We have also initiated work on the second phase of the certification, further demonstrating our dedication to achieving full compliance.

While the formal confirmation of the first audit is pending, our application is already technically anchored to the DSQ. This achievement underscores the robustness of our development efforts and our readiness to proceed through the remaining stages of certification.

“This milestone represents a pivotal step forward in our journey to full DSQ integration, reflecting the substantial progress we have made toward delivering a seamless and secure connection for our users. We remain confident in our ability to complete the certification process and unlock the full potential of this integration for our platform,” stated Marc Lemieux, Chief Executive Officer and Chairman of Board of KDA.

 

ABOUT KDA GROUP

KDA Group is a leader in technological innovations and specialized software solutions (SaaS – Software as a service) for the healthcare professionals’ market. KDA is a corporation that offers quality products and has respected expertise among the various stakeholders in the pharmaceutical and medical sectors. The technology products developed by KDA aim, among other things, to accelerate the healthcare’s digital transformation, and are available for the Canadian and international markets. Additional information about the Corporation is available at www.groupkda.com and on SEDAR+ at www.sedarplus.ca.

 

- 30 -

 

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

 

This press release from KDA Group contains forward-looking statements. Forward-looking statements are typically identified by the words assumption, goal, guidance, objective, outlook, strategy, target, and other similar expressions, or future or conditional verbs such as aim, anticipate, believe, predict, could, expect, intend, may, plan, seek, should, strive, and will. By their nature, forward-looking statements require us to make estimates and assumptions and express opinions based on current conditions and anticipated developments, as well as other factors that Management may deem appropriate under the circumstances. There is inherent uncertainty and significant risk in these estimates, assumptions, and opinions, particularly of a commercial, economic, and competitive nature, and they are therefore subject to change. KDA Group cannot guarantee that these estimates, assumptions, and opinions will prove to be accurate.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

 

INFORMATION

Marc Lemieux, Chief Executive Officer

514 622-7370

info@groupkda.com